izpis_h1_title_alt

Relationship between excreted uremic toxins and degree of disorder of children with ASD
ID Osredkar, Joško (Author), ID Žvar Baškovič, Barbara (Author), ID Finderle, Petra (Author), ID Bobrowska-Korczak, Barbara (Author), ID Gątarek, Paulina (Author), ID Rosiak, Angelina (Author), ID Giebułtowicz, Joanna (Author), ID Jekovec-Vrhovšek, Maja (Author), ID Kałużna-Czaplińska, Joanna (Author)

.pdfPDF - Presentation file, Download (1,13 MB)
MD5: FAAFA4E07169B259E35EF983FBDC0ABF
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/24/8/7078 This link opens in a new window

Abstract
Autism spectrum disorder (ASD) is a complex developmental disorder in which communication and behavior are affected. A number of studies have investigated potential biomarkers, including uremic toxins. The aim of our study was to determine uremic toxins in the urine of children with ASD (143) and compare the results with healthy children (48). Uremic toxins were determined with a validated high-performance liquid chromatography coupled to mass spectrometry (LC-MS/MS) method. We observed higher levels of p-cresyl sulphate (pCS) and indoxyl sulphate (IS) in the ASD group compared to the controls. Moreover, the toxin levels of trimethylamine N-oxide (TMAO), symmetric dimethylarginine (SDMA), and asymmetric dimethylarginine (ADMA) were lower in ASD patients. Similarly, for pCS and IS in children classified, according to the intensity of their symptoms, into mild, moderate, and severe, elevated levels of these compounds were observed. For mild severity of the disorder, elevated levels of TMAO and comparable levels of SDMA and ADMA for ASD children as compared to the controls were observed in the urine. For moderate severity of ASD, significantly elevated levels of TMAO but reduced levels of SDMA and ADMA were observed in the urine of ASD children as compared to the controls. When the results obtained for severe ASD severity were considered, reduced levels of TMAO and comparable levels of SDMA and ADMA were observed in ASD children.

Language:English
Keywords:uremic toxins, autism spectrum disorder, ASD, degree of deficit
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:14 str.
Numbering:Vol. 24, iss. 8, art. 7078
PID:20.500.12556/RUL-145165 This link opens in a new window
UDC:616.896
ISSN on article:1422-0067
DOI:10.3390/ijms24087078 This link opens in a new window
COBISS.SI-ID:148468227 This link opens in a new window
Publication date in RUL:12.04.2023
Views:548
Downloads:107
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:uremični toksini, motnje avtističnega spektra, MAS, stopnja primanjkljaja

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-1756
Name:Okoljski in genetski dejavniki pri motnjah avtističnega spektra

Funder:ARRS - Slovenian Research Agency
Project number:P3-0124
Name:Metabolni in prirojeni dejavniki reproduktivnega zdravja, porod III

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back